Tag Archives: After

Fauci Likely to Birth His Own COVID Variant After Paxlovid

Pfizer’s Paxlovid was granted emergency use authorization to treat mild to moderate COVID-19 in December 2021.1 The drug consists of nirmatrelvir tablets — the antiviral component — and ritonavir tablets, which are intended to slow the breakdown of nirmatrelvir.2 What started out as a slow rollout — only 40,000 or fewer prescriptions were written for… Read More »

Swisscom and SANDSIV Look Forward to Continued Success After Celebrating Year One of Their Partnership

SANDSIV’s highly secure, hyper-modern, on-premises VoC solution has enhanced Swisscom’s position as a leader in Customer Experience ZURICH, Switzerland (May, 31 2022) — Swisscom, Switzerland’s leading telecommunications provider, and SANDSIV, the global leader in Customer Experience Management (CXM) and Voice of the Customer (VoC) enterprise solutions, are celebrating year one of a successful partnership that… Read More »

088: Abs after baby with Daisy Andrea Bravo

Hi friends! Happy Thursday! I’ve got a new episode up on the ‘pod and today I’m chatting with Daisy Andrea Bravo about abs after baby. When you hear “abs after baby,” it’s easy to think about getting a six-pack (or getting your six-pack back) because that’s the messaging that we’re constantly bombarded with online. I’m… Read More »

FDA says Moderna vaccine’s benefits outweigh risks after Nordic countries limit use

The U.S. Food and Drug Administration reiterated its stance that the benefits of Moderna’s COVID-19 vaccine outweigh its risks on Friday after several Nordic countries began restricting its use for certain age groups due to concerns about a rare heart-related side effect. The FDA responded after health officials in Finland said Thursday that males under… Read More »

Pfizer’s Covid efficacy against infection plunges to 20% after six months, data from Qatar shows

Pfizer’s Covid vaccine efficacy against infection plunges to just 20% after six months – but protection against severe illness barely dips, study concludes Pfizer’s protection against catching Covid drops to just 20% within six months Effectiveness against severe illness and death remains high for at least 6 months  The study used data from Qatar, where… Read More »

Just SIX out of every 1 million develop rare heart inflammation after a second dose of vaccine

Just SIX in 1 million people develop rare heart inflammation after a second dose of the Covid vaccine – 85% less than the rate among the unvaccinated, study finds Less than out of every one million people develop myocarditis after the first shot of a Covid vaccine, and around six develop it after the second… Read More »